CJC-1295 vs Sermorelin: GHRH Analogue Comparison
CJC-1295
GH SecretagogueCJC-1295 is a synthetic analogue of growth hormone-releasing hormone (GHRH). It extends the half-life of GHRH from minutes to days, providing sustained GH stimulation.
View full profile →Sermorelin
GH SecretagogueSermorelin is a synthetic version of the first 29 amino acids of growth hormone-releasing hormone (GHRH). It was the first GHRH analogue approved by the FDA for treating GH deficiency in children.
View full profile →Comparison Overview
CJC-1295 and Sermorelin are both GHRH (growth hormone-releasing hormone) analogues that stimulate GH release through the same receptor pathway. The critical difference lies in their pharmacokinetics. Sermorelin is the first 29 amino acids of native GHRH with a half-life of roughly 10-20 minutes, while CJC-1295 has been modified to dramatically extend its duration of action—particularly the DAC (Drug Affinity Complex) version, which binds to albumin and can maintain elevated GH levels for days.
Sermorelin's short half-life means it produces acute GH pulses that closely mimic natural physiology, then clears quickly. CJC-1295 without DAC (also called Mod GRF 1-29) has a half-life of about 30 minutes, while CJC-1295 with DAC can last 6-8 days. This extended activity means fewer administrations but a less physiological, more sustained GH elevation pattern.
The choice between them often comes down to research goals around dosing frequency and GH release pattern. Researchers prioritizing natural pulsatile release may prefer Sermorelin, while those studying sustained GH elevation or seeking less frequent dosing protocols may lean toward CJC-1295.
Key Differences
| Category | CJC-1295 | Sermorelin |
|---|---|---|
| Half-Life | ~30 min (no DAC) or 6-8 days (with DAC) | ~10-20 minutes |
| GH Release Pattern | Sustained elevation (DAC) or extended pulse (no DAC) | Acute, natural-pattern pulsatile release |
| Dosing Frequency | Less frequent dosing possible, especially with DAC | Typically requires more frequent administration |
| FDA History | No FDA approval | Previously FDA-approved (pediatric GH deficiency) |
| Common Stacking | Frequently combined with Ipamorelin (GHRP) | Often used standalone or with a GHRP |
| Physiological Profile | Modified structure for extended action | Closer to natural GHRH signaling |
Overlapping Research Areas
- GH optimization
- Anti-aging research
- Body composition
- Recovery protocols
- Sleep quality research
Which One to Research?
Researchers valuing convenience and sustained GH elevation may prefer CJC-1295, particularly the DAC version for less frequent dosing. Those prioritizing a more physiological GH release pattern with natural feedback preservation may find Sermorelin more appropriate. CJC-1295 (no DAC) combined with Ipamorelin has become one of the most popular research stacks in the GH secretagogue space.
⚠️ Important: This comparison is for informational and educational purposes only. It does not constitute medical advice. Consult a qualified healthcare professional before making any decisions regarding peptide use.
Learn More in the Peptide Playbook
Get comprehensive protocols, dosing information, and vendor selection guidance.
Get the Full Guide →